アメナメビル
gov/pmc/articles/PMC5697646/6
↑ “Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor”. Antiviral Research 139: 95–101. (March 2017). doi:10.1016/j.antiviral.2016.12.008. PMID 280279176
↑ "Maruho Receives Manufacturing and Marketing Approval for Anti-Herpes Virus Agent "Amenalief® Tab. 200mg" in Japan" (Press release). evaluategroup.com. 3 July 2017.